BC
BMO Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
651
Ovintiv
OVV
$10.6B
|
PJ
Phillip Jungwirth
| $41.05 | $51 |
24%
upside
| Market Perform |
7 Mar ‘23
2 years ago |
|
652
Amneal Pharmaceuticals
AMRX
$3.06B
|
GN
Gary Nachman
| $9.73 | $4 |
59%
downside
| Market Perform |
3 Mar ‘23
2 years ago |
|
653
Hayward Holdings
HAYW
$3.51B
|
JJ
John Joyner
| $16.21 | $12 |
26%
downside
| Market Perform |
2 Mar ‘23
2 years ago |
|
654
Phathom Pharmaceuticals
PHAT
$882M
|
GN
Gary Nachman
| $12.43 | $30 |
141%
upside
| Outperform |
1 Mar ‘23
2 years ago |
|
655
Structure Therapeutics
GPCR
$1.2B
|
ES
Evan Seigerman
| $20.86 | $40 |
92%
upside
| Outperform |
28 Feb ‘23
2 years ago |
|
656
Ionis Pharmaceuticals
IONS
$9.72B
|
GN
Gary Nachman
| $61 | $67 |
10%
upside
| Outperform |
23 Feb ‘23
2 years ago |
|
657
AbCellera Biologics
ABCL
$1.25B
|
GN
Gary Nachman
| $4.17 | $32 |
667%
upside
| Outperform |
22 Feb ‘23
2 years ago |
|
658
Viatris
VTRS
$12.2B
|
GN
Gary Nachman
| $10.48 | $14 |
34%
upside
| Market Perform |
17 Feb ‘23
2 years ago |
|
659
SSR Mining
SSRM
$4.34B
|
RT
Ryan Thompson
| $21.39 | $19 |
11%
downside
| Outperform |
14 Feb ‘23
2 years ago |
|
660
PayPal
PYPL
$65.3B
|
JF
James Fotheringham
| $68.40 | $108 |
58%
upside
| Outperform |
13 Feb ‘23
2 years ago |
|
661
Trane Technologies
TT
$92.3B
|
JJ
John Joyner
| $414.93 | $180 |
57%
downside
| Market Perform |
12 Feb ‘23
2 years ago |
|
662
Regional Management Corp
RM
$424M
|
JF
James Fotheringham
| $43.22 | $37 |
14%
downside
| Market Perform |
10 Feb ‘23
2 years ago |
|
663
Mattel
MAT
$5.96B
|
GJ
Gerrick Johnson
| $18.50 | $27 |
46%
upside
| Outperform |
10 Feb ‘23
2 years ago |
|
664
Malibu Boats
MBUU
$636M
|
GJ
Gerrick Johnson
| $33.03 | $80 |
142%
upside
| Outperform |
8 Feb ‘23
2 years ago |
|
665
AbbVie
ABBV
$371B
|
GN
Gary Nachman
| $209.79 | $167 |
20%
downside
| Outperform |
6 Feb ‘23
2 years ago |
|
666
Methanex
MEOH
$3.02B
|
JJ
Joel Jackson
| $39 | $65 |
67%
upside
| Outperform |
6 Feb ‘23
2 years ago |
|
667
SLM Corp
SLM
$6.35B
|
JF
James Fotheringham
| $30.44 | $17 |
44%
downside
| Market Perform |
6 Feb ‘23
2 years ago |
|
668
NXP Semiconductors
NXPI
$56.9B
|
AS
Ambrish Srivastava
| $225.50 | $180 |
20%
downside
| Market Perform |
1 Feb ‘23
2 years ago |
|
669
Nucor
NUE
$33.1B
|
DG
David Gagliano
| $144.02 | $165 |
15%
upside
| Market Perform |
27 Jan ‘23
2 years ago |
|
670
Navient
NAVI
$1.35B
|
JF
James Fotheringham
| $13.61 | $19 |
40%
upside
| Market Perform |
26 Jan ‘23
2 years ago |
|
671
Alcoa
AA
$8.3B
|
DG
David Gagliano
| $32.04 | $50 |
56%
upside
| Market Perform |
19 Jan ‘23
2 years ago |
|
672
Pacira BioSciences
PCRX
$1.2B
|
GN
Gary Nachman
| $26.74 | $52 |
94%
upside
| Market Perform |
6 Jan ‘23
2 years ago |
|
673
Kura Sushi USA
KRUS
$970M
|
AS
Andrew Strelzik
| $80.19 | $53 |
34%
downside
| Market Perform |
6 Jan ‘23
2 years ago |
|
|
LENZ
674
LENZ Therapeutics
LENZ
$1.13B
|
KB
Kostas Biliouris
| $39.63 | $49 |
24%
upside
| Market Perform |
6 Jan ‘23
2 years ago |
|
675
Hasbro
HAS
$11.1B
|
GJ
Gerrick Johnson
| $79.36 | $66 |
17%
downside
| Market Perform |
4 Jan ‘23
2 years ago |
|